Patent · US Active

Hemostatic bone graft

US8545864B2 · kind B2 · utility

20Cited by
171References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 5, 2007
Grant dateOct 1, 2013
Priority date
Expiry dateMay 9, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2400/04
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

The present invention provides a hemostatic bone graft product and method. Hemostatic bone grafts may include demineralized bone matrix in combination with additives. In one embodiment, the graft comprises demineralized bone and polyethylene glycol. Methods for producing the hemostatic bone graft may include mixing demineralized bone with additives to facilitate protein precipitation, surface tension reduction in blood, and/or a cytolytic effect on cells at a bleeding site.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.